117 related articles for article (PubMed ID: 31462154)
21. Voriconazole Composited Polyvinyl Alcohol/Hydroxypropyl-β-Cyclodextrin Nanofibers for Ophthalmic Delivery.
Sun X; Yu Z; Cai Z; Yu L; Lv Y
PLoS One; 2016; 11(12):e0167961. PubMed ID: 27974859
[TBL] [Abstract][Full Text] [Related]
22. Dispersion of daidzein with polyvinylpyrrolidone effects on dissolution rate and bioavailability.
Feng BL; Li HW; Zhou MY; Lu W
Zhong Yao Cai; 2011 Apr; 34(4):605-10. PubMed ID: 21809547
[TBL] [Abstract][Full Text] [Related]
23. Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.
Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
Ann Pharmacother; 2009 Dec; 43(12):2103-7. PubMed ID: 19861430
[TBL] [Abstract][Full Text] [Related]
24. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
25. Pioglitazone solid dispersion system prepared by spray drying method: in vitro and in vivo evaluation.
Pokharkar V; Kutwal M; Mandpe L
PDA J Pharm Sci Technol; 2013; 67(1):23-34. PubMed ID: 23385561
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
27. Solid carriers for improved solubility of glipizide in osmotically controlled oral drug delivery system.
Mehramizi A; Alijani B; Pourfarzib M; Dorkoosh FA; Rafiee -Tehrani M
Drug Dev Ind Pharm; 2007 Aug; 33(8):812-23. PubMed ID: 17729098
[TBL] [Abstract][Full Text] [Related]
28. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
Gorajana A; Kit WW; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
[TBL] [Abstract][Full Text] [Related]
29. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.
Asyarie S; Rachmawati H
PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178
[TBL] [Abstract][Full Text] [Related]
30. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
[TBL] [Abstract][Full Text] [Related]
31. Development of solid dispersion systems of dapivirine to enhance its solubility.
Gorajana A; Ying CC; Shuang Y; Fong P; Tan Z; Gupta J; Talekar M; Sharma M; Garg S
Curr Drug Deliv; 2013 Jun; 10(3):309-16. PubMed ID: 23360246
[TBL] [Abstract][Full Text] [Related]
32. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
Sethia S; Squillante E
Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
[TBL] [Abstract][Full Text] [Related]
33. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
Zhao X; Liu X; Gan L; Zhou C; Mo J
Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
[TBL] [Abstract][Full Text] [Related]
34. Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers.
Ng CL; Lee SE; Lee JK; Kim TH; Jang WS; Choi JS; Kim YH; Kim JK; Park JS
Int J Pharm; 2016 Oct; 512(1):314-321. PubMed ID: 27593897
[TBL] [Abstract][Full Text] [Related]
35. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of domperidone solid dispersions.
Essa EA; Balata GF
Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
[TBL] [Abstract][Full Text] [Related]
37. Development of a Sustained-Release Voriconazole-Containing Thermogel for Subconjunctival Injection in Horses.
Cuming RS; Abarca EM; Duran S; Wooldridge AA; Stewart AJ; Ravis W; Babu RJ; Lin YJ; Hathcock T
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2746-2754. PubMed ID: 28549089
[TBL] [Abstract][Full Text] [Related]
38. Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design.
Kyaw Oo M; Mandal UK; Chatterjee B
Pharm Dev Technol; 2017 Feb; 22(1):2-12. PubMed ID: 26616399
[TBL] [Abstract][Full Text] [Related]
39. Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate.
Srikanth Meka V; Wee Liang VA; Dharmalingham SR; Sheshala R; Gorajana A
Acta Pharm; 2014 Dec; 64(4):485-94. PubMed ID: 25531788
[TBL] [Abstract][Full Text] [Related]
40. Optimized molecular imprints in gamma-irradiated collagen shields of an antifungal drug: In vitro characterization, in-vivo bioavailability enhancement.
Abouelatta SM; Sheta AI; Ibrahim RR
Eur J Pharm Biopharm; 2021 Sep; 166():135-143. PubMed ID: 34166761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
